GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
GC Biopharma USA, Inc., a leader in plasma-derived products, announced today that it will host a lunch symposium and support three scientific presentations at the 2026 Clinical Immunology Society (CIS) Annual Meeting, taking place May 6 to 9 in New Orleans, Louisiana. GC Biopharma’s presentations at CIS will include two company-authored posters and one EpiVax-led poster supported through GC Biopharma’s Investigator-Initiated Research Program.
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
GC Biopharma USA, Inc., a leader in plasma-derived products, today announced the presentation of new research evaluating the aggregation profiles, including molecular size distribution and particle size, in commercially available intravenous immunoglobulin (IVIG) products. The data will be presented at the 2026 National Home Infusion Association (NHIA) Annual Conference, taking place April 18–22, in Denver, Colorado.
